Gupta R K, Saxena S N, Sharma S B, Ahuja S
Division of Biological Standardization and Quality Control, Central Research Institute, Kasauli, India.
Vaccine. 1990 Dec;8(6):563-8. doi: 10.1016/0264-410x(90)90009-b.
The immunogenicity of different types of glutaraldehyde inactivated pertussis vaccine (GIPV) preparations made by inactivation of Bordetella pertussis organisms with different concentrations of glutaraldehyde for variable periods at room temperature and conventional heat inactivated pertussis vaccine (HIPV) was evaluated with regard to production of agglutinins and neutralizing antibodies against pertussis toxin (PT). The different types of GIPV preparations had variable intracerebral mouse potency which depended upon the conditions of inactivation with glutaraldehyde. The agglutinin production in mice against various types of GIPV preparations and HIPV were very similar irrespective of the potency of the preparations. The agglutinins were produced against all the three major agglutinogens 1, 2 and 3 as the preparations were made from B. pertussis strain 10536 (serotype 1,2,3). The titres of agglutinins produced against adjuvanted preparations were slightly higher than those against non-adjuvanted preparations. Neutralizing antibodies against PT were produced for eight out of nine types of GIPV preparations while these antibodies were not produced for conventional HIPV.
评估了不同类型的戊二醛灭活百日咳疫苗(GIPV)制剂以及传统热灭活百日咳疫苗(HIPV)的免疫原性,这些GIPV制剂是通过在室温下用不同浓度的戊二醛对百日咳博德特氏菌进行不同时长的灭活而制成的,评估内容包括针对百日咳毒素(PT)的凝集素和中和抗体的产生情况。不同类型的GIPV制剂具有不同的脑内小鼠效力,这取决于戊二醛的灭活条件。无论制剂效力如何,小鼠针对各种类型的GIPV制剂和HIPV产生的凝集素非常相似。由于制剂是由百日咳博德特氏菌10536菌株(血清型1、2、3)制成的,所以针对所有三种主要凝集原1、2和3都产生了凝集素。针对佐剂化制剂产生的凝集素滴度略高于针对非佐剂化制剂产生的凝集素滴度。九种GIPV制剂中有八种产生了针对PT的中和抗体,而传统HIPV未产生这些抗体。